Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Centogene N.V. (CNTG)

Centogene N.V. (CNTG)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Centogene N.V. (CNTG) Stock Jumps 7.5%: Will It Continue to Soar?

Centogene N.V. (CNTG) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase...

CNTG : 11.39 (+0.53%)
Zacks Industry Outlook Highlights: Computer Programs and Systems, Centogene and Cerner

Zacks Industry Outlook Highlights: Computer Programs and Systems, Centogene and Cerner

CERN : 81.91 (+2.25%)
CPSI : 31.50 (+0.13%)
CNTG : 11.39 (+0.53%)
CENTOGENE Initiates EFRONT Study to Identify Patients With Genetic Forms of Frontotemporal Dementia

Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on generating data-driven insights to diagnose, understand, and treat rare diseases, today announced a new observational study to understand...

CNTG : 11.39 (+0.53%)
ALEC : 25.79 (+1.78%)
STERIS (STE) to Report Q4 Earnings: What's in the Cards?

STERIS (STE) is likely to have continued to gain from the robust demand of PPE and COVID-19-related products in Q4.

COO : 423.98 (+0.09%)
STE : 218.94 (+0.28%)
BWAY : 8.60 (-4.44%)
CNTG : 11.39 (+0.53%)
Centogene (CNTG) Enters Oversold Territory

Centogene (CNTG) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock

CNTG : 11.39 (+0.53%)
4 Medical Products Stocks Set to Beat This Earnings Season

Rebound in base sales make us optimistic about OMI, INGN, XRAY and CNTG's results this time around.

XRAY : 65.34 (-2.05%)
OMI : 42.76 (-8.83%)
HOLX : 75.74 (-0.12%)
BSX : 45.54 (-0.74%)
LH : 300.08 (+0.83%)
INGN : 78.14 (-0.69%)
CNTG : 11.39 (+0.53%)
Centogene Reports Financial Results For Full Year 2019 and Highlights Recent Progress

Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians and pharmaceutical...

CNTG : 11.39 (+0.53%)
PFE : 45.68 (+3.91%)
Coronavirus Scare Supports These Biotech ETFs & Stocks

Growing coronavirus concerns provide some support to these biotech ETFs and stocks amid a massive market sell-off.

IBB : 169.40 (+2.14%)
CNCR : 29.33 (+0.24%)
BBH : 211.75 (+2.03%)
ARKG : 84.79 (+0.39%)
AYTU : 3.89 (-3.23%)
FTSV : 95.51 (+0.05%)
VIR : 34.90 (-2.68%)
IDNA : 51.08 (+1.63%)
CODX : 10.31 (+3.51%)
CNTG : 11.39 (+0.53%)
CENTOGENE Announces Changes in Supervisory Board

CENTOGENE N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical...

QGEN : 52.49 (-0.57%)
CNTG : 11.39 (+0.53%)
EVT : 27.64 (+0.80%)
CENTOGENE Signs Data Access and Collaboration Agreement with Pfizer Inc.

CENTOGENE (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians and pharmaceutical...

CNTG : 11.39 (+0.53%)
PFE : 45.68 (+3.91%)

Barchart Exclusives

US Crop Production Forecast Raised on Higher Yields
Corn and soybean futures are lower after Barchart raised its end-of season production forecasts for U.S. field crops. According to Barchart's CSO Keith Petersen, their "forecasts for US field crop production have been revised higher on the back of increased yield expectations for both corn (180.2 bu/ac vs. 176.5 in... Read more

Barchart Futures Commentary

Barchart Futures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar